Maternal outcomes among pregnant women receiving live attenuated influenza vaccine

Influenza and other Respiratory Viruses

Volumn 6, Issue 1, 2012, Pages 44-51

  Toback, Seth L ^a   Beigi, Richard ^b   Tennis, Patricia ^c   Sifakis, Frangiscos ^a   Calingaert, Brian ^c   Ambrose, Christopher S ^a  

^a MEDIMMUNE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c RTI HEALTH SOLUTIONS   (United States)

Author keywords

Inactivated influenza vaccine; Live attenuated influenza vaccine; Pregnancy; Safety

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; BRONCHITIS; FEMALE; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; HYPEREMESIS GRAVIDARUM; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MATERNAL AGE; PATIENT SAFETY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL;

ADOLESCENT; ADULT; DRUG TOXICITY; FEMALE; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 83555166260     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2011.00266.x     Document Type: Article

References (32)

1. Fiore AE, Uyeki TM, Broder K et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1-62.
2. Lindsay L, Jackson LA, Savitz DA et al. Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women. Am J Epidemiol 2006; 163:838-848.
3. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148:1094-1102.
4. American College of Obstetricians and Gynecologists (ACOG). Immunization updates for pregnant women in influenza season 2010 Available at: (Accessed 6 April 2011).
5. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 2008; 8:44-52.
6. Munoz FM, Greisinger AJ, Wehmanen OA et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005; 192:1098-1106.
7. Centers for Disease Control and Prevention. Guidelines for vaccinating pregnant women. 2010 Available at: (Accessed 6 April 2011).
8. Moro PL, Broder K, Zheteyeva Y et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol 2011; 204:146.e1-146.e7.
9. Piedra PA, Gaglani MJ, Riggs M et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18months to 4years, 5 to 9years, and 10 to 18years of age in a community-based, nonrandomized, open-label trial. Pediatrics 2005; 116:e397-e407.
10. Tran CH, McElrath J, Hughes P et al. Implementing a community-supported school-based influenza immunization program. Biosecur Bioterror 2010; 8:331-341.
11. Martin JA, Hamilton BE, Sutton PD et al. Births: Final Data for 2006 National Vital Statistics Reports; vol 57 no 7. Hyattsville, MD, National Center for Health Statistics, 2009.
12. Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker AM. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007; 16:474-484.
13. Andrade SE, Raebel MA, Morse AN et al. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 2006; 15:546-554.
14. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005; 11:527-539.
15. Bennett TA, Kotelchuck M, Cox CE, Tucker MJ, Nadeau DA. Pregnancy-associated hospitalizations in the United States in 1991 and 1992: a comprehensive view of maternal morbidity. Am J Obstet Gynecol 1998; 178:346-354.
16. McPheeters ML, Miller WC, Hartmann KE et al. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol 2005; 192:1325-1329; discussion 1329-1330.
17. Jolley JA, Wing DA. Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes. Drugs 2010; 70:1643-1655.
18. Millar LK, Cox SM. Urinary tract infections complicating pregnancy. Infect Dis Clin North Am 1997; 11:13-26.
19. Banhidy F, Acs N, Puho EH, Czeizel AE. Maternal acute respiratory infectious diseases during pregnancy and birth outcomes. Eur J Epidemiol 2008; 23:29-35.
20. Nichol KL, Mendelman PM, Mallon KP et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999; 282:137-144.
21. Treanor JJ, Kotloff K, Betts RF et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 1999; 18:899-906.
22. Fleming DM, Crovari P, Wahn U et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006; 25:860-869.
23. Gorse GJ, O'Connor TZ, Young SL et al. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. Chest 2006; 130:1109-1116.
24. Cardwell MS. Polyhydramnios: a review. Obstet Gynecol Surv 1987; 42:612-617.
25. Giuntoli R, Yeh IT, Bhuett N, Chu W, Van Leewen K, Van der Lans P. Conservative management of cervical intraepithelial neoplasia during pregnancy. Gynecol Oncol 1991; 42:68-73.
26. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-1952.
27. Toback SL, Falloon J, Ambrose CS. Case reports on maternal and fetal outcomes after exposure to LAIV during pregnancy. National Immunization Conference; 2010 April 19-22; Atlanta, GA.
28. FluMist® (Influenza Virus Vaccine Live, Intranasal, Full prescribing information). Full Prescribing Information. Gaithersburg, MD: MedImmune, 2010.
29. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998; 47:1-57.
30. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-40.
31. Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ 1997; 315:32-34.
32. Wilcox AJ, Weinberg CR, O'Connor JF et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319:189-194.